Selected article for: "entry assay and Gluc entry"

Author: de Vries, Erik; Tscherne, Donna M.; Wienholts, Marleen J.; Cobos-Jiménez, Viviana; Scholte, Florine; García-Sastre, Adolfo; Rottier, Peter J. M.; de Haan, Cornelis A. M.
Title: Dissection of the Influenza A Virus Endocytic Routes Reveals Macropinocytosis as an Alternative Entry Pathway
  • Document date: 2011_3_31
  • ID: 05lnj3w0_13
    Snippet: FCS) during entry (the first 2 h of infection) and were removed when the inoculum was replaced by growth medium containing BafA1. Concentrations up to 80 mM dynasore did not inhibit entry which is in agreement with the result shown in Fig. 1B . In contrast, 1.25 nM BafA1 already inhibited entry for more than 60% (Fig. 1F) . As a control, dynasore was also added at 2 hrs post infection to analyze whether the drug affected IAV replication during th.....
    Document: FCS) during entry (the first 2 h of infection) and were removed when the inoculum was replaced by growth medium containing BafA1. Concentrations up to 80 mM dynasore did not inhibit entry which is in agreement with the result shown in Fig. 1B . In contrast, 1.25 nM BafA1 already inhibited entry for more than 60% (Fig. 1F) . As a control, dynasore was also added at 2 hrs post infection to analyze whether the drug affected IAV replication during the post entry phase. As expected, 80 mM dynasore did not significantly inhibit IAV replication when present from 2 to 16 hrs p.i. (Fig. 1F ). Thus, with the Gluc-entry assay we can study the effect of specific inhibitors on IAV entry in a quantitative manner, at least as long as the inhibitors do not irreversibly affect IAV replication during the post entry phase.

    Search related documents:
    Co phrase search for related documents
    • entry phase and Gluc entry assay: 1, 2
    • entry phase and growth medium: 1, 2
    • entry phase and hrs post: 1
    • entry phase and hrs post infection: 1
    • entry phase and IAV entry: 1, 2
    • entry phase and IAV replication: 1
    • entry phase and IAV replication affect: 1
    • entry phase and post entry phase: 1, 2
    • Gluc entry and growth medium: 1, 2
    • Gluc entry and hrs post: 1, 2
    • Gluc entry and hrs post infection: 1, 2
    • Gluc entry and IAV entry: 1, 2, 3, 4, 5, 6, 7
    • Gluc entry and IAV replication: 1
    • Gluc entry and IAV replication affect: 1
    • Gluc entry and post entry phase: 1
    • Gluc entry assay and IAV entry: 1, 2, 3, 4, 5, 6, 7
    • Gluc entry assay and IAV replication: 1
    • Gluc entry assay and IAV replication affect: 1
    • Gluc entry assay and post entry phase: 1